This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| Anglo American | Morgan Stanley cuts TP to 1500p from 1760p, Equalweight |
| ASOS | HSBC ups TP to 8200p from 7160p, overweight |
| AstraZeneca | Liberum ups TP to 4600p; keeps Buy rating |
| Beazley | Numis downgrades to add from Buy |
| Datatec | Finncap cuts TP to 430p from 470p |
| Firstgroup | HSBC ups TP to 155p from 115p, neutral |
| Go-Ahead | HSBC ups TP to 2180p from 1810p, overweight |
| Hays | HSBC ups TP to 157p from 140p, overweight |
| Hiscox | Numis ups to add from Hold |
| International Consolidated Airlines | Barclays ups TP to 500p from 300p, overweight |
| Intertek | Berenberg downgrades to Hold from Buy |
| Kentz Corporation | HSBC ups TP to 775p from 615p, overweight |
| National Express | HSBC downgrades to neutral from overweight |
| Pennon Group | Morgan Stanley ups TP to 723p from 685p, Equalweight |
| Severn Trent | Morgan Stanley cuts TP to 1696p from 1730p, Equalweight |
| Shire | Berenberg ups TP to 2900p from 2350p, Hold |
| Stagecoach | HSBC ups to overweight from neutral |
| Standard Chartered | SocGen cuts TP to 1550p from 1800p, Buy |
| SThree | HSBC ups TP to 388p from 355p, neutral |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research